首页/数据集/Additional file 15 of Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer

Additional file 15 of Identification and validation of genes associated with prognosis of cisplatin-resistant ovarian cancer

NIAID Data Ecosystem2026-05-02 收录

卵巢癌耐药性

癌症预后生物标志物

数据链接：

https://figshare.com/articles/dataset/Additional_file_15_of_Identification_and_validation_of_genes_associated_with_prognosis_of_cisplatin-resistant_ovarian_cancer/26710502 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 15.

应用场景：

创建时间：

2024-08-05

相关数据集

Clinical phases of HFRS.

肾综合征出血热临床分期

癌症预后生物标志物

ObjectiveThe increase in vascular permeability and bleeding caused by systemic endothelial damage is the most basic pathological change of hemorrhagic fever with renal syndrome(HFRS) caused by Hantavi

Figshare2026-03-20 更新50

Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models

卵巢癌耐药性

癌细胞药物反应

Ovarian cancers are still largely treated with platinum-based chemotherapy as the standard of care, yet few biomarkers of clinical response have had an impact on clinical decision making as of yet. Tw

NIAID Data Ecosystem30

Table8_Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma.XLSX

癌症预后生物标志物

肿瘤蛋白功能分析

Prefoldins (PFDNs), a group of proteins known to be associated with cytoskeletal rearrangement, are involved in tumor progression in various cancer types. However, little is known about the roles of P

NIAID Data Ecosystem20

Table2_Single-cell RNA sequencing analysis to explore immune cell heterogeneity and novel biomarkers for the prognosis of lung adenocarcinoma.xls

肿瘤免疫微环境

癌症预后生物标志物

Background: Single-cell RNA sequencing is necessary to understand tumor heterogeneity, and the cell type heterogeneity of lung adenocarcinoma (LUAD) has not been fully studied. Method: We first reduce

NIAID Data Ecosystem40

DataSheet_1_Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma.pdf

肿瘤免疫微环境分析

癌症预后生物标志物

The existence of intratumoral tertiary lymphoid structure (iTLS) has been reported to correlative with favorable clinical outcomes for patients with hepatocellular carcinoma (HCC). However, little is

NIAID Data Ecosystem30